Astellas's Vesicare insurance price plan hits snag

Published: 2007-10-25 06:59:00

Updated: 2007-10-25 06:59:00

Astellas Pharma Korea wrapped its second round of Vesicare (solifenacin succinate) insurance price talks with the National Health Insurance Corporation without substantial progress.

Astellas proposed the insurance price of 1,310 won for 5 mg tablet and 1,400 won for 10 mg, while the NHIC sugge...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK